Quantitative Systematic Strategies’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-13,452
Closed -$917K 430
2021
Q2
$917K Sell
13,452
-11,649
-46% -$759K 0.32% 81
2021
Q1
$1.74M Sell
25,101
-105
-0.4% -$8.08K 0.27% 110
2020
Q4
$1.94M Buy
25,206
+2,799
+12% +$210K 0.27% 106
2020
Q3
$1.68M Sell
22,407
-3,701
-14% -$247K 0.29% 99
2020
Q2
$1.64M Buy
26,108
+13,982
+115% +$769K 0.32% 85
2020
Q1
$509K Buy
12,126
+789
+7% +$36.2K 0.42% 84
2019
Q4
$515K Buy
+11,337
New +$536K 0.08% 328

Other funds holding ARNA

Quantitative Systematic Strategies's ARNA Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2021, closing a stake of 13,452 shares — an estimated $917K sold.

Quantitative Systematic Strategies first reported a position in ARNA in Q4 2019 and held it in 7 quarters. The position peaked at $1.94M in Q4 2020. 235 funds tracked by Wall St. Rank hold ARNA as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining Arena Pharmaceuticals Inc position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 13,452 Arena Pharmaceuticals Inc shares in Q3 2021, an estimated $917K.
  • Quantitative Systematic Strategies first reported a position in Arena Pharmaceuticals Inc in Q4 2019 and held it in 7 quarters.
  • Quantitative Systematic Strategies's Arena Pharmaceuticals Inc position peaked at $1.94M in Q4 2020.
  • 235 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.